Data / Drug companies / Melanin Synthesis Inhibitor
Melanin Synthesis Inhibitor drugs: 3 drugs from 15 companies in the FDA NDC directory
Melanin Synthesis Inhibitor is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 24 products in this class from 15 companies, covering 3 drugs by generic name. The main marketing category is other unapproved drugs, and the newest product started marketing on September 13, 2024.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 15Companies
- 24Products
- 3Drugs by generic name
Drugs in the Melanin Synthesis Inhibitor class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Hydroquinone | 18 | 12 |
| Fluocinolone acetonide, hydroquinone, and tretinoin | 1 | 1 |
| Hydroquinone, octinoxate, and oxybenzone | 1 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Obagi Cosmeceuticals LLC | 6 | cream; solution | Other unapproved drugs | January 1, 2010 |
| Guna Spa | 3 | solution/ drops | Unapproved homeopathic products | May 23, 2006 |
| Zo Skin Health, Inc. | 3 | emulsion | Other unapproved drugs | May 1, 2018 |
| Acella Pharmaceuticals, LLC | 1 | cream | Other unapproved drugs | September 10, 2014 |
| Akron Pharma Inc. | 1 | cream | Other unapproved drugs | September 13, 2024 |
| Apnar Pharma LP | 1 | cream | Other unapproved drugs | November 1, 2021 |
| Bryant Ranch Prepack | 1 | cream | Other unapproved drugs | August 17, 2022 |
| Dermavance Pharmaceuticals | 1 | gel | Other unapproved drugs | December 8, 2008 |
| Deseret Biologicals, Inc. | 1 | liquid | Unapproved homeopathic products | July 9, 2019 |
| Galderma Laboratories, L.P. | 1 | cream | New drug applications (NDA) | January 18, 2002 |
| Marlex Pharmaceuticals, Inc. | 1 | cream | Other unapproved drugs | March 1, 2021 |
| Nivagen Pharmaceuticals, Inc. | 1 | cream | Other unapproved drugs | August 17, 2022 |
| O Skin Care LLC | 1 | cream | Other unapproved drugs | May 4, 2022 |
| Sohm, Inc | 1 | cream | Other unapproved drugs | June 5, 2023 |
| Westminster Pharmaceuticals, LLC | 1 | cream | Other unapproved drugs | April 16, 2018 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Cream | 13 | 54.2% |
| Emulsion | 3 | 12.5% |
| Solution/ drops | 3 | 12.5% |
| Liquid | 2 | 8.3% |
| Solution | 1 | 4.2% |
| Gel | 1 | 4.2% |
| Lotion | 1 | 4.2% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.